Molecular Profile | Unknown unknown |
Therapy | Midostaurin |
Indication/Tumor Type | Advanced Solid Tumor |
Response Type | not applicable |
Create By | csp |
Update By | spatt |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References | Unknown unknown | Advanced Solid Tumor | not applicable | Midostaurin | Phase I | Actionable | In a Phase I trial, Rydapt (midostaurin) demonstrated safety in patients with advanced solid tumors (PMID: 11230495). | 11230495 |
---|
PubMed Id | Reference Title | Details |
---|---|---|
(11230495) | Phase I and pharmacokinetic study of PKC412, an inhibitor of protein kinase C. | Full reference... |